Soya, maize and sorghum ready-to-use therapeutic foods are more effective in correcting anaemia and iron deficiency than the standard ready-to-use therapeutic food: randomised controlled trial. BMC Public Health, (2019); 19:806
Soya, maize, and sorghum–based ready-to-use therapeutic food with amino acid is as efficacious as the standard milk and peanut paste–based formulation for the treatment of severe acute malnutrition in children: A noninferiority individually randomized controlled efficacy clinical trial in Malawi. AJCN, 2017; 106: 1100/12
Comparison of the effectiveness of a milk-free soy-maize-sorghum-based ready-to-use therapeutic food to standard ready-to-use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non-blinded cluster randomised controlled trial, Maternal and Child Nutrition.
At the Global Hunger Today Conference, Dr Steve Collins raised challenging questions about undue delays in the implementation of robust, scientific evidence that can transform the numbers of malnourished children receiving treatment within existing budgets.
The ground-breaking results from a clinical trial of a Ready-to-Use Therapeutic Food (RUTF) product made without milk or animal source protein and undertaken in Malawi in 2016, were recently unveiled by VALID Nutrition’s Founder, Dr Steve Collins.
Food Assistance for Nutrition Evidence Summit on June 27th and 28th, 2018 in Washington D.C.
“It is scandalous that a product with several critical advantages and high quality scientific evidence to support it, can be blocked because of bureaucracy and vested interests”